Aperio Group’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $1.08M | Sell |
16,655
-63
| -0.4% | -$4.09K | ﹤0.01% | 1554 |
|
|
2020
Q3 | $789K | Sell |
16,718
-942
| -5% | -$44.5K | ﹤0.01% | 1566 |
|
|
2020
Q2 | $830K | Buy |
17,660
+749
| +4% | +$35.2K | ﹤0.01% | 1499 |
|
|
2020
Q1 | $755K | Buy |
16,911
+2,215
| +15% | +$98.9K | ﹤0.01% | 1424 |
|
|
2019
Q4 | $857K | Sell |
14,696
-1,324
| -8% | -$77.2K | ﹤0.01% | 1509 |
|
|
2019
Q3 | $963K | Buy |
16,020
+487
| +3% | +$29.3K | ﹤0.01% | 1407 |
|
|
2019
Q2 | $868K | Sell |
15,533
-1,831
| -11% | -$102K | ﹤0.01% | 1471 |
|
|
2019
Q1 | $968K | Sell |
17,364
-790
| -4% | -$44K | ﹤0.01% | 1385 |
|
|
2018
Q4 | $819K | Sell |
18,154
-638
| -3% | -$28.8K | ﹤0.01% | 1416 |
|
|
2018
Q3 | $1.24M | Sell |
18,792
-1,733
| -8% | -$114K | 0.01% | 1284 |
|
|
2018
Q2 | $1.32M | Sell |
20,525
-224
| -1% | -$14.4K | 0.01% | 1229 |
|
|
2018
Q1 | $1.15M | Buy |
20,749
+612
| +3% | +$33.9K | 0.01% | 1242 |
|
|
2017
Q4 | $964K | Sell |
20,137
-1,684
| -8% | -$80.6K | ﹤0.01% | 1321 |
|
|
2017
Q3 | $1.1M | Buy |
21,821
+865
| +4% | +$43.7K | 0.01% | 1209 |
|
|
2017
Q2 | $1.14M | Buy |
20,956
+2,906
| +16% | +$158K | 0.01% | 1168 |
|
|
2017
Q1 | $760K | Sell |
18,050
-13,642
| -43% | -$574K | 0.01% | 1298 |
|
|
2016
Q4 | $680K | Buy |
31,692
+16,894
| +114% | +$362K | 0.01% | 1336 |
|
|
2016
Q3 | $611K | Buy |
14,798
+262
| +2% | +$10.8K | ﹤0.01% | 1337 |
|
|
2016
Q2 | $580K | Sell |
14,536
-1,024
| -7% | -$40.9K | ﹤0.01% | 1311 |
|
|
2016
Q1 | $524K | Buy |
15,560
+2,784
| +22% | +$93.8K | ﹤0.01% | 1342 |
|
|
2015
Q4 | $433K | Buy |
12,776
+2,740
| +27% | +$92.9K | ﹤0.01% | 1414 |
|
|
2015
Q3 | $299K | Sell |
10,036
-2,040
| -17% | -$60.8K | ﹤0.01% | 1565 |
|
|
2015
Q2 | $333K | Sell |
12,076
-345
| -3% | -$9.51K | ﹤0.01% | 1566 |
|
|
2015
Q1 | $313K | Buy |
12,421
+1,940
| +19% | +$48.9K | ﹤0.01% | 1541 |
|
|
2014
Q4 | $232K | Buy |
+10,481
| New | +$232K | ﹤0.01% | 1660 |
|